OverviewChartNewsTraderScreen

BVT Put 940 LLY 20.09.2024/  DE000VD9RTT4  /

Frankfurt Zert./VONT
06/09/2024  13:53:10 Chg.+0.570 Bid15:35:39 Ask15:35:39 Underlying Strike price Expiration date Option type
3.910EUR +17.07% 2.810
Bid Size: 15,000		 2.830
Ask Size: 15,000		 ELI LILLY 940.00 - 20/09/2024 Put
GlobeNewswire 03/09 Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
Newsfile Corp 28/08 The GLP-1 Products and Players - Expanding a new Era of Pharmaceutical Products for Diabetes and Wei...
GlobeNewswire 27/08 Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund’s 2024 Corporate Membership...
GlobeNewswire 26/08 Eliem Therapeutics Announces Additions to its Leadership Team
GlobeNewswire 21/08 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Co...
GlobeNewswire 21/08 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Co...
GlobeNewswire 19/08 Tiziana Life Sciences Appoints New Chief Executive Officer
GlobeNewswire 14/08 Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s ...
GlobeNewswire 14/08 Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD...
TeleTrader 09/08 US trades up premarket after yesterday's earnings
TeleTrader 08/08 Wall Street rallies at close, Dow soars 680 pts
GlobeNewswire 08/08 Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Cl...
TeleTrader 08/08 US opens higher with data, earnings in focus
GlobeNewswire 08/08 ProQR Announces Second Quarter 2024 Operating and Financial Results
TeleTrader 08/08 Eli Lilly's Q2 revenue jumps 36% to $11.3B
GlobeNewswire 08/08 Defiance Launches LLYX, the First 2X Leveraged Single-Stock ETF on Eli Lilly
TeleTrader 08/08 US down premarket as volatility persists
GlobeNewswire 07/08 Pattern Announces Company Presentation at LSX World Congress USA
GlobeNewswire 06/08 Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Rea...
GlobeNewswire 06/08 SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discov...
GlobeNewswire 02/08 Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Cl...
GlobeNewswire 01/08 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
GlobeNewswire 01/08 COUR Pharmaceuticals Announces Leadership Transition for Strategic Growth Objectives
GlobeNewswire 31/07 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFC, HMNF, MORF on Behalf of Shareholders
GlobeNewswire 31/07 MORF Alert: Wohl & Fruchter LLP Files Class Action Lawsuit on Behalf of Shareholders of Morphic Hold...